1. 27PPREDMED®, a normalized expression signature of drug targets versus reference tissues aiming at generalizing treatment personalization. (16th September 2018) Authors: Verlingue, L; Baranger, M; Gianesini, C; Fritz, J; Schaeffer, M; Malka, D; Jouffroy, C; Loubaton, B; Bagnard, D Journal: Annals of oncology Issue: Volume 29:Number 6(2018)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 781TiPPRODIGE 29-UCGI 26(NEOPAN): A randomised trial of chemotherapy with folfirinox or gemcitabine in locally advanced pancreatic carcinoma (PC). (23rd October 2018) Authors: Ducreux, M P; Desgrippes, R; Texier, M; Di Fiore, F; Vanelslander, P; Capitain, O; Guimbaud, R; Forestier, J; El Hajbi, F; Follana, P; Parzy, A; Baba Hamed, N; Rinaldi, Y; Brotelle, T; Pignon, J-P; Jouffroy, C; Dahan, L; Bouche, O Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗